GENSIGHT BIOLOGICS

GENSIGHT BIOLOGICS is a SA à conseil d'administration (s.a.i.) in PARIS 12, France with 12 ISIN-identified securities mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 11 years, since 31 Aug 2015. That is about 5 years earlier than the median LEI in France, which dates from 2021 — an early adopter by local standards.

The next annual re-validation is due 28 Apr 2027, 174 days from now.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Register of Companies (Sirene) under registry number 751164757, and the LEI itself is issued and maintained by INSTITUT NATIONAL DE LA STATISTIQUE ET DES ETUDES ECONOMIQUES, one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 12 ISINs are mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.